Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-25 @ 8:25 PM
Study NCT ID:
NCT03463369
Status:
COMPLETED
Last Update Posted:
2021-04-14
First Post:
2018-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed
Sponsor:
Janssen Sciences Ireland UC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-23
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-28
First Submit QC Date:
None
Study First Post Date:
2018-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-13
Last Update Post Date:
2021-04-14
Last Update Post Date Type:
ACTUAL